This disclosure concerns fatty acid derivatives, pharmaceutical compositions comprising the fatty acid derivatives, and methods of using the fatty acid derivatives, for example, to treat inflammation, chronic itch, chronic pain, an autoimmune disorder, atherosclerosis, a skin disorder, arthritis, a neurodegenerative disorder, or a psychiatric disorder in a subject. In some embodiments, the fatty acid derivative is a compound, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof, having a structure according to:

##STR00001##

wherein X is from 1-16 carbons in length, Z is aliphatic from 1-16 carbons in length, or is not present, Y is selected from:

##STR00002##

R.sup.1, R.sup.2, and R.sup.3 are independently hydrogen or lower alkyl, R.sup.4 is lower alkyl, hydroxyl, carboxyl, or amine, R.sup.5 is hydrogen, lower alkyl, or halide, R.sup.6 is hydroxyl or substituted thiol, and each R.sup.7 is independently hydrogen or fluoride or is not present and the adjacent carbons form alkyne.

The present invention relates to a process of hydrogenating an alkyne selectively to an alkene by hydrogen using a hydrogenation catalyst which is palladium supported on a carrier in the presence of an additive mixture of an organic phosphorus compound (AP) and an organic sulphur compound (AS).

The present invention relates to a process of hydrogenating an alkyne selectively to an alkene by hydrogen using a hydrogenation catalyst which is palladium supported on a carrier in the presence of an additive mixture of an organic phosphorus compound (AP) and an organic sulphur compound (AS).

A method of reducing an aromatic ring or a cyclic, allylic ether in a compound includes preparing a reaction mixture including a compound including an aromatic moiety or a cyclic, allylic ether moiety, an alkali metal, and either ethylenediamine, diethylenetriamine, triethylenetetramine, or a combination thereof, in an ether solvent; and reacting the reaction mixture at from −20° C. to 30° C. for a time sufficient to reduce a double bond in the aromatic moiety to a single bond or to reduce the cyclic, allylic ether moiety.

A method of reducing an aromatic ring or a cyclic, allylic ether in a compound includes preparing a reaction mixture including a compound including an aromatic moiety or a cyclic, allylic ether moiety, an alkali metal, and either ethylenediamine, diethylenetriamine, triethylenetetramine, or a combination thereof, in an ether solvent; and reacting the reaction mixture at from −20° C. to 30° C. for a time sufficient to reduce a double bond in the aromatic moiety to a single bond or to reduce the cyclic, allylic ether moiety.

The present invention relates to odorous 2- and/or 3-substituted 3-(allyloxy)propenes which are useful as fragrance or flavor ingredients in particular in providing green, fruity, pear and/or waxy olfactory notes. The present invention also relates to novel perfume, aroma or deodorizing/masking compositions comprising said odorants.

The present invention relates to odorous 2- and/or 3-substituted 3-(allyloxy)propenes which are useful as fragrance or flavor ingredients in particular in providing green, fruity, pear and/or waxy olfactory notes. The present invention also relates to novel perfume, aroma or deodorizing/masking compositions comprising said odorants.

The present invention discloses a selective hydrogenation catalyst and a preparation method and an application thereof, belonging to the technical field of catalysts. The selective hydrogenation catalyst comprises an active component and a carrier for supporting the active component, wherein the active component is a transition metal particle, the carrier is modified by a flexible chain ligand in advance, one end of the flexible chain ligand is uniformly distributed on the surface of the carrier, and the other end of the flexible chain ligand is coordinated on a transition metal. When the catalyst is used for catalytic hydrogenation reaction of dehydrolinalool or 2-methyl-3-butyn-2-ol, the stability is good, the catalyst still has high selectivity after being used for a long time, and the quality of a hydrogenation product can be guaranteed.

The present invention discloses a selective hydrogenation catalyst and a preparation method and an application thereof, belonging to the technical field of catalysts. The selective hydrogenation catalyst comprises an active component and a carrier for supporting the active component, wherein the active component is a transition metal particle, the carrier is modified by a flexible chain ligand in advance, one end of the flexible chain ligand is uniformly distributed on the surface of the carrier, and the other end of the flexible chain ligand is coordinated on a transition metal. When the catalyst is used for catalytic hydrogenation reaction of dehydrolinalool or 2-methyl-3-butyn-2-ol, the stability is good, the catalyst still has high selectivity after being used for a long time, and the quality of a hydrogenation product can be guaranteed.

The present invention discloses a selective hydrogenation catalyst and a preparation method and an application thereof, belonging to the technical field of catalysts. The selective hydrogenation catalyst comprises an active component and a carrier for supporting the active component, wherein the active component is a transition metal particle, the carrier is modified by a flexible chain ligand in advance, one end of the flexible chain ligand is uniformly distributed on the surface of the carrier, and the other end of the flexible chain ligand is coordinated on a transition metal. When the catalyst is used for catalytic hydrogenation reaction of dehydrolinalool or 2-methyl-3-butyn-2-ol, the stability is good, the catalyst still has high selectivity after being used for a long time, and the quality of a hydrogenation product can be guaranteed.